SCHEMBL8532525

SCHEMBL8532525

NNC(=O)CCc1ccc(S)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HIF1A Q16665 1/20 0.51
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC2 Q92769 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 1/20 0.42
AOC3 Q16853 2/20 0.41
KDM1A O60341 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6037022 0.82 HDAC2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2836138 0.81 CYP3A4 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL27606163 0.81 LMNA (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17967143 0.81 HDAC1 (0.57) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL967387 0.80 HDAC2 (0.68) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4409663 0.79 FFAR1 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1367862 0.78 TRPV1 (0.60) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7817965 0.77 LMNA (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13903016 0.77 ALDH1A1 (0.67) ALDH1A1MAPTL3MBTL1HTT
SCHEMBL26497798 0.77 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770701-A Process for preparing targeted forms of methyltrithio antitumor agents AMERICAN CYANAMID COMPANY (US) 1998-06-23 US claimed
US-5770710-A REACTING METHYLTRITHIO ANTIBIOTIC LL-E32288 DERIVATIVE WITH MERCAPTAN COMPOUND AMERICAN CYANAMID COMPANY (US) 1998-06-23 US claimed
US-5770701-A Process for preparing targeted forms of methyltrithio antitumor agents AMERICAN CYANAMID COMPANY (US) 1998-06-23 US disclosed
US-5770710-A REACTING METHYLTRITHIO ANTIBIOTIC LL-E32288 DERIVATIVE WITH MERCAPTAN COMPOUND AMERICAN CYANAMID COMPANY (US) 1998-06-23 US disclosed
EP-0392384-B1 Targeted forms of methyltrithio antitumor agents AMERICAN CYANAMID CO (US) 1998-02-18 EP disclosed
US-5606040-A DERIVATIZED OLIGOSACCHARIDE ANTIBIOTICS WITH CHROMOPHORE AMERICAN CYANAMID COMPANY (US) 1997-02-25 US disclosed
US-5053394-A Protein-drug reaction product AMERICAN CYANAMID COMPANY (US) 1991-10-01 US disclosed
EP-0392384-A2 Targeted forms of methyltrithio antitumor agents AMERICAN CYANAMID COMPANY (US) 1990-10-17 EP disclosed